Abstract Information

The Abstract Submission to EULAR 2012 Berlin is closed.

Please read this information carefully!

• Abstract submission must be in one of the four different categories:
  a. Medical or Research Professional / Clinician
  b. Health Professional in Rheumatology / Practice and Research
  c. PARE Member / Patient
  d. Primary Care
  
  The categories are subdivided into topics (Abstract topics >>).
  The correct category and topic must be selected to ensure correct scoring. The content of the abstract must be topic related.
  
• Please carefully read all instructions in the abstract submission system before preparing your abstract.
• For standardisation, the acceptable length of the abstract is not more than 3600 characters and 50 lines, author's details and headers included. This also includes non-visible characters such as spaces and punctuation.
  
• The abstract should be structured into the following sections:
  a. Title which clearly indicates the nature of the investigation
  b. Background
  c. Objectives
  d. Methods
  e. Results
  f. Conclusions
  g. References
  
• One graph/image can be included with the following criteria:
  Max image width: 750 pixels
  Max image height: 750 pixels
  Image quality: min. 96 dpi - max. 600 dpi
  Max file size: 500 KB
  Allowed file type: gif, jpg
  Please note that insertion of graphs and images may significantly reduce the number of remaining allowed characters.
  
• Abstracts can be saved in "Draft" status to be finalised until the submission deadline (31 January 2012, midnight CET). Therefore, the submitter will be required to create a user account.
  
• Abstracts fulfilling all criteria can be saved in "Final submission" status. Only abstracts in "Final submission" status will be regarded as successfully submitted and considered for the congress. Abstracts in "Final submission" status can be reedited and modified until the submission deadline
  (31 January 2012, midnight CET).
  
• An abstract can only be submitted if the "Rules and Regulations" on the online abstract form are accepted.
  
• Conflict of interest: It is the intent of EULAR to provide highquality sessions focused on educational content that is free from commercial influence or bias. Thus the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during the abstracts submission.
  
• Abstracts accepted for the congress are subject to the "Abstract Embargo Rules" and the "Transfer of Copyright". Please note the links in the right column.
  
• The corresponding author has the right to grant, and does grant, on behalf of all authors an exclusive licence on a worldwide basis to the BMJ Publishing Group Ltd and EULAR to publish the abstract (if accepted) in any media and to exploit all subsidiary rights.
  
• Only abstracts that contain original data can be submitted.
  
• Abstracts should not be submitted if the following applies:
• the abstract contains data that has been published or accepted for publication in a print or on-line journal.
• the abstract contains data that was presented at a scientific meeting more than 12 months prior to EULAR 2012.
• The reviewers will judge the abstracts according to the scientific or clinical value, relevance to EULAR, suitability of methods to aims, conclusions confirmed by objective results, objectivity of statements, description of methods used, ethics, originality of work, standard of English and overall impression.
  
• Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced exactly as submitted. No proofreading will be done.
  
• Accepted abstracts will be published either in the congress abstract book, a supplement to "The Annals of the Rheumatic Diseases The EULAR Journal", or on USB keys which will be distributed to participants together with the congress bag. Accepted abstracts will also be available on-line on the EULAR website, about one month prior to the congress and thereafter in the EULAR Abstracts archives.
  
• The submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session and the time assigned by the EULAR Scientific Committee. We therefore recommend that submitters of abstracts register for the congress simultaneously with abstract submission.
  
• Abstracts not adhering to these guidelines will be rejected. If you do not agree with any of these rules, you should not submit an abstract. The final decision about acceptance of an abstract will be taken by the EULAR Scientific Committee. EULAR does not correspond on the acceptance/rejection of an abstract.
  
• If you need to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to the EULAR Secretariat or MCI not later than 15 April 2012.

Instructions for Abstract Presentations

• If an abstract is selected for oral presentation, the presenting author as specified at submission will be requested to present it in the assigned session. Details will be communicated to the author by mid-April 2012.
  

• If an abstract is accepted as a poster presentation, the presenting author will be requested to be available for discussion during the corresponding poster viewing session.
  

• Posters will be set up close to the exhibition area.
  
• The posters need to be printed in landscape. The usable surface of the display panels measures 94 cm (height) x 180 cm (width); adhesive material will be provided.
  
• Please use letters large enough to be read from a distance of 1.5 meters.